In Depth 1 Aug 2025
Oncolytic virus therapy for cancer: what’s been going on in 2025?
This past year has seen various developments in the field of oncolytic virus therapies – in fundraising and in the clinic.
In Depth
- Latest Posts
In Depth 30 Jul 2025
Targeting orexin: the future of narcolepsy treatments
There are a few new narcolepsy treatments being tested in the clinic, and recently, some of them have made promising strides. But how far along are they?
In Depth 18 Jul 2025
Hyderabad’s Genome Valley, biopharma’s scale-up hub
Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.
In Depth 17 Jul 2025
New horizons in sickle cell disease treatment: Promising therapies on the way
Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.
In Depth 16 Jul 2025
Eight rare autoimmune diseases biotechs are fighting to treat
Discover eight rare autoimmune diseases you may not have heard of and what biotechs are doing to treat them.
In Depth 9 Jul 2025
New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage?
Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval.
ADVERTISEMENT
ADVERTISEMENT
In Depth 8 Jul 2025
The biggest biotech funding rounds in June 2025
The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June 2025.
In Depth 7 Jul 2025
Biotech in Vienna: a budding life science hub
As biotech in Vienna raked in €22.7 billion in 2023, there has been a significant increase in innovation, research, and employment in recent years.
In Depth 3 Jul 2025
Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer
Find out how CAR-T cell therapy, which has been so groundbreaking in treating blood cancers, could potentially cure glioblastoma.
In Depth 1 Jul 2025
Is an HIV cure possible? The future of HIV therapy
Delve into the field of HIV treatment development. Since the virus was discovered, treatments have improved, but are we close to a cure?
In Depth 27 Jun 2025
Psychedelics sans side effects: neuroplastogens gain ground
The past year has seen several developments in the neuroplastogens field, including Elkedonia’s seed funding to address neuropsychiatric disorders.
In Depth 25 Jun 2025
ALS: how close are we to a cure?
Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.
ADVERTISEMENT
